Clinical Trials
2 trialsNCT07131722 2026-01-23
Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
PRG Science & Technology Co., Ltd.
Phase 1/2 Not yet recruiting
NCT05521048 2025-12-08
Doxycycline in Cutaneous Schwannoma (NF2)
Massachusetts Eye and Ear Infirmary
Phase 1/2 Active not recruiting